Press Releases Search News Category Company ReleasesCompany StatementsFinancial ReleasesProduct Releases Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title PDF Version Apr 16, 2010 Alexion's Soliris(R) (Eculizumab) Receives Marketing Approval in Japan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Apr 08, 2010 Alexion Pharmaceuticals to Report First Quarter Results on Thursday, April 22, 2010 Mar 02, 2010 Alexion to Present at the Cowen and Company 30th Annual Health Care Conference Feb 26, 2010 Alexion Joins NORD, EURORDIS and Other Patient Advocacy Groups in Supporting the Goals of Rare Disease Day 2010 Feb 24, 2010 Alexion Appoints Andreas Rummelt to its Board of Directors Feb 11, 2010 Alexion Reports Fourth Quarter and Full Year 2009 Results Jan 28, 2010 Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2009 Results on February 11, 2010 Jan 06, 2010 Alexion to Present at the 28th Annual JP Morgan Healthcare Conference Dec 07, 2009 Soliris(R) Reduced Hemolysis, Lowered Thrombosis Rate and Improved Quality of Life in Patients with PNH Who Had Previously Never Been Transfused Dec 07, 2009 Soliris® Reversed Thrombocytopenia in Patients with Both PNH and Pre-Existing Thrombocytopenia in Study Presented at ASH Annual Meeting Pagination First page « first Previous page ‹ previous … Page 46 Page 47 Page 48 Page 49 Current page 50 Page 51 Page 52 Page 53 Page 54 … Next page next › Last page last » Displaying 491 - 500 of 631